Amgen MEA’s Mohamed Nasser* examines the current pharma commercialisation model, posits how the entire healthcare ecosystem’s rapid and effective…

Biogen’s manager for the Middle East, Africa, Russia & CIS, Turkey (MART), Ajai Sulekh, discusses the company’s five-pillar strategy to expand…

Siemens Healthineers’ CEO for the Middle East and Southern and Eastern Africa, Ole Per Maloy, outlines the company’s different business models in…

Aspen’s regional CEO for the Middle East, North Africa & Turkey, Daniel Vella Friggieri, provides insights into how the South African…

Over a decade ago, GE Healthcare selected Turkey as an international operational base for its Eastern and Africa Growth Markets (EAGM) and 84…

Altibbi's Ayman Sharaiha outlines the evolution of the company to date to become the largest digital health platform in MENA, explains how the…

Frederico Silva outlines the highlights of his two years heading up Gilead Sciences' relatively young Middle-East affiliate, how Gilead has pivoted to…

Biologix is a Dubai-based firm that represents international pharma companies by bringing innovative drugs to market in the Middle East / North Africa…

3M, an American multinational conglomerate, has been in the limelight since the beginning of the COVID-19 pandemic primarily as one of the leading…

Boehringer Ingelheim’s Regional Managing Director and Head of Human Pharma in the Middle East, Turkey, and Africa (‘META’) Mohammed Al-Tawil…

Evren Özlü, General Manager of Turkey and Sub-Saharan Africa at Boehringer Ingelheim, discusses the company’s double-digit growth in the last…

As our thoughts here at PharmaBoardroom turn towards the summer holidays, we are happy to share the five most-read articles from our global…